Steroid-induced Deficiency of Mucosal-associated Invariant T Cells in the Chronic Obstructive Pulmonary Disease Lung. Implications for Nontypeable Haemophilus influenzae Infection
Mucosal-associated invariant T (MAIT) cells are a recently described abundant, proinflammatory T-cell subset with unknown roles in pulmonary immunity. Nontypeable Haemophilus influenzae (NTHi) is the leading bacterial pathogen during chronic obstructive pulmonary disease (COPD) exacerbations and is...
Saved in:
Published in | American journal of respiratory and critical care medicine Vol. 194; no. 10; pp. 1208 - 1218 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Thoracic Society
15.11.2016
|
Subjects | |
Online Access | Get full text |
ISSN | 1073-449X 1535-4970 1535-4970 |
DOI | 10.1164/rccm.201601-0002OC |
Cover
Loading…
Abstract | Mucosal-associated invariant T (MAIT) cells are a recently described abundant, proinflammatory T-cell subset with unknown roles in pulmonary immunity. Nontypeable Haemophilus influenzae (NTHi) is the leading bacterial pathogen during chronic obstructive pulmonary disease (COPD) exacerbations and is a plausible target for MAIT cells.
To investigate whether MAIT cells respond to NTHi and the effects of inhaled corticosteroids (ICS) on their frequency and function in COPD.
Eleven subjects with COPD receiving ICS, 8 steroid-naive subjects with COPD, and 21 healthy control subjects underwent phlebotomy, sputum induction, bronchoalveolar lavage, and endobronchial biopsy. Pulmonary and monocyte-derived macrophages were cultured in vitro with NTHi.
Frequencies of Vα7.2
CD161
MAIT cells, surface expression of the major histocompatibility complex-related protein 1 (MR1), and intracellular IFN-γ expression were measured by flow cytometry. MAIT-cell frequencies were reduced in peripheral blood of ICS-treated subjects with COPD (median 0.38%; interquartile range [IQR], 0.25-0.96) compared with healthy control subjects (1.8%; IQR, 1.4-2.5; P = 0.001) or steroid-naive patients with COPD (1.8%; IQR, 1.2-2.3; P = 0.04). MAIT cells were reduced in bronchial biopsies from subjects with COPD treated with steroids (0.73%; IQR, 0.46-1.3) compared with healthy control subjects (4.0%; IQR, 1.6-5.0; P = 0.02). Coculture of live NTHi increased macrophage surface expression of MR1 and induced IFN-γ from CD4 cells and CD8 cells, but most potently from MAIT cells (median IFN-γ-positive frequencies, 2.9, 8.6, and 27.6%, respectively). In vitro fluticasone and budesonide reduced MR1 surface expression twofold and decreased NTHi-induced IFN-γ secretion eightfold.
MAIT cells are deficient in blood and bronchial tissue in steroid-treated, but not steroid-naive, COPD. NTHi constitutes a target for pulmonary MAIT-cell immune responses, which are significantly impaired by corticosteroids. |
---|---|
AbstractList | Rationale:
Mucosal-associated invariant T (MAIT) cells are a recently described abundant, proinflammatory T-cell subset with unknown roles in pulmonary immunity. Nontypeable
Haemophilus influenzae
(NTHi) is the leading bacterial pathogen during chronic obstructive pulmonary disease (COPD) exacerbations and is a plausible target for MAIT cells.
Objectives:
To investigate whether MAIT cells respond to NTHi and the effects of inhaled corticosteroids (ICS) on their frequency and function in COPD.
Methods:
Eleven subjects with COPD receiving ICS, 8 steroid-naive subjects with COPD, and 21 healthy control subjects underwent phlebotomy, sputum induction, bronchoalveolar lavage, and endobronchial biopsy. Pulmonary and monocyte-derived macrophages were cultured
in vitro
with NTHi.
Measurements and Main Results:
Frequencies of Vα7.2
+
CD161
+
MAIT cells, surface expression of the major histocompatibility complex–related protein 1 (MR1), and intracellular IFN-γ expression were measured by flow cytometry. MAIT-cell frequencies were reduced in peripheral blood of ICS-treated subjects with COPD (median 0.38%; interquartile range [IQR], 0.25–0.96) compared with healthy control subjects (1.8%; IQR, 1.4–2.5;
P
= 0.001) or steroid-naive patients with COPD (1.8%; IQR, 1.2–2.3;
P
= 0.04). MAIT cells were reduced in bronchial biopsies from subjects with COPD treated with steroids (0.73%; IQR, 0.46–1.3) compared with healthy control subjects (4.0%; IQR, 1.6–5.0;
P
= 0.02). Coculture of live NTHi increased macrophage surface expression of MR1 and induced IFN-γ from CD4 cells and CD8 cells, but most potently from MAIT cells (median IFN-γ–positive frequencies, 2.9, 8.6, and 27.6%, respectively).
In vitro
fluticasone and budesonide reduced MR1 surface expression twofold and decreased NTHi-induced IFN-γ secretion eightfold.
Conclusions:
MAIT cells are deficient in blood and bronchial tissue in steroid-treated, but not steroid-naive, COPD. NTHi constitutes a target for pulmonary MAIT-cell immune responses, which are significantly impaired by corticosteroids. Mucosal-associated invariant T (MAIT) cells are a recently described abundant, proinflammatory T-cell subset with unknown roles in pulmonary immunity. Nontypeable Haemophilus influenzae (NTHi) is the leading bacterial pathogen during chronic obstructive pulmonary disease (COPD) exacerbations and is a plausible target for MAIT cells.RATIONALEMucosal-associated invariant T (MAIT) cells are a recently described abundant, proinflammatory T-cell subset with unknown roles in pulmonary immunity. Nontypeable Haemophilus influenzae (NTHi) is the leading bacterial pathogen during chronic obstructive pulmonary disease (COPD) exacerbations and is a plausible target for MAIT cells.To investigate whether MAIT cells respond to NTHi and the effects of inhaled corticosteroids (ICS) on their frequency and function in COPD.OBJECTIVESTo investigate whether MAIT cells respond to NTHi and the effects of inhaled corticosteroids (ICS) on their frequency and function in COPD.Eleven subjects with COPD receiving ICS, 8 steroid-naive subjects with COPD, and 21 healthy control subjects underwent phlebotomy, sputum induction, bronchoalveolar lavage, and endobronchial biopsy. Pulmonary and monocyte-derived macrophages were cultured in vitro with NTHi.METHODSEleven subjects with COPD receiving ICS, 8 steroid-naive subjects with COPD, and 21 healthy control subjects underwent phlebotomy, sputum induction, bronchoalveolar lavage, and endobronchial biopsy. Pulmonary and monocyte-derived macrophages were cultured in vitro with NTHi.Frequencies of Vα7.2+CD161+ MAIT cells, surface expression of the major histocompatibility complex-related protein 1 (MR1), and intracellular IFN-γ expression were measured by flow cytometry. MAIT-cell frequencies were reduced in peripheral blood of ICS-treated subjects with COPD (median 0.38%; interquartile range [IQR], 0.25-0.96) compared with healthy control subjects (1.8%; IQR, 1.4-2.5; P = 0.001) or steroid-naive patients with COPD (1.8%; IQR, 1.2-2.3; P = 0.04). MAIT cells were reduced in bronchial biopsies from subjects with COPD treated with steroids (0.73%; IQR, 0.46-1.3) compared with healthy control subjects (4.0%; IQR, 1.6-5.0; P = 0.02). Coculture of live NTHi increased macrophage surface expression of MR1 and induced IFN-γ from CD4 cells and CD8 cells, but most potently from MAIT cells (median IFN-γ-positive frequencies, 2.9, 8.6, and 27.6%, respectively). In vitro fluticasone and budesonide reduced MR1 surface expression twofold and decreased NTHi-induced IFN-γ secretion eightfold.MEASUREMENTS AND MAIN RESULTSFrequencies of Vα7.2+CD161+ MAIT cells, surface expression of the major histocompatibility complex-related protein 1 (MR1), and intracellular IFN-γ expression were measured by flow cytometry. MAIT-cell frequencies were reduced in peripheral blood of ICS-treated subjects with COPD (median 0.38%; interquartile range [IQR], 0.25-0.96) compared with healthy control subjects (1.8%; IQR, 1.4-2.5; P = 0.001) or steroid-naive patients with COPD (1.8%; IQR, 1.2-2.3; P = 0.04). MAIT cells were reduced in bronchial biopsies from subjects with COPD treated with steroids (0.73%; IQR, 0.46-1.3) compared with healthy control subjects (4.0%; IQR, 1.6-5.0; P = 0.02). Coculture of live NTHi increased macrophage surface expression of MR1 and induced IFN-γ from CD4 cells and CD8 cells, but most potently from MAIT cells (median IFN-γ-positive frequencies, 2.9, 8.6, and 27.6%, respectively). In vitro fluticasone and budesonide reduced MR1 surface expression twofold and decreased NTHi-induced IFN-γ secretion eightfold.MAIT cells are deficient in blood and bronchial tissue in steroid-treated, but not steroid-naive, COPD. NTHi constitutes a target for pulmonary MAIT-cell immune responses, which are significantly impaired by corticosteroids.CONCLUSIONSMAIT cells are deficient in blood and bronchial tissue in steroid-treated, but not steroid-naive, COPD. NTHi constitutes a target for pulmonary MAIT-cell immune responses, which are significantly impaired by corticosteroids. Mucosal-associated invariant T (MAIT) cells are a recently described abundant, proinflammatory T-cell subset with unknown roles in pulmonary immunity. Nontypeable Haemophilus influenzae (NTHi) is the leading bacterial pathogen during chronic obstructive pulmonary disease (COPD) exacerbations and is a plausible target for MAIT cells. To investigate whether MAIT cells respond to NTHi and the effects of inhaled corticosteroids (ICS) on their frequency and function in COPD. Eleven subjects with COPD receiving ICS, 8 steroid-naive subjects with COPD, and 21 healthy control subjects underwent phlebotomy, sputum induction, bronchoalveolar lavage, and endobronchial biopsy. Pulmonary and monocyte-derived macrophages were cultured in vitro with NTHi. Frequencies of Vα7.2 CD161 MAIT cells, surface expression of the major histocompatibility complex-related protein 1 (MR1), and intracellular IFN-γ expression were measured by flow cytometry. MAIT-cell frequencies were reduced in peripheral blood of ICS-treated subjects with COPD (median 0.38%; interquartile range [IQR], 0.25-0.96) compared with healthy control subjects (1.8%; IQR, 1.4-2.5; P = 0.001) or steroid-naive patients with COPD (1.8%; IQR, 1.2-2.3; P = 0.04). MAIT cells were reduced in bronchial biopsies from subjects with COPD treated with steroids (0.73%; IQR, 0.46-1.3) compared with healthy control subjects (4.0%; IQR, 1.6-5.0; P = 0.02). Coculture of live NTHi increased macrophage surface expression of MR1 and induced IFN-γ from CD4 cells and CD8 cells, but most potently from MAIT cells (median IFN-γ-positive frequencies, 2.9, 8.6, and 27.6%, respectively). In vitro fluticasone and budesonide reduced MR1 surface expression twofold and decreased NTHi-induced IFN-γ secretion eightfold. MAIT cells are deficient in blood and bronchial tissue in steroid-treated, but not steroid-naive, COPD. NTHi constitutes a target for pulmonary MAIT-cell immune responses, which are significantly impaired by corticosteroids. |
Author | Staples, Karl J. Wilkinson, Tom M. A. Hinks, Timothy S. C. Djukanović, Ratko Williams, Anthony P. Wallington, Joshua C. |
Author_xml | – sequence: 1 givenname: Timothy S. C. surname: Hinks fullname: Hinks, Timothy S. C. organization: Clinical & Experimental Sciences and, Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, United Kingdom, Department for Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia; and – sequence: 2 givenname: Joshua C. surname: Wallington fullname: Wallington, Joshua C. organization: Clinical & Experimental Sciences and – sequence: 3 givenname: Anthony P. surname: Williams fullname: Williams, Anthony P. organization: Cancer Sciences, University of Southampton Faculty of Medicine, Sir Henry Wellcome Laboratories, Southampton General Hospital, Southampton, United Kingdom, Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, United Kingdom – sequence: 4 givenname: Ratko surname: Djukanović fullname: Djukanović, Ratko organization: Clinical & Experimental Sciences and, Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, United Kingdom – sequence: 5 givenname: Karl J. orcidid: 0000-0003-3844-6457 surname: Staples fullname: Staples, Karl J. organization: Clinical & Experimental Sciences and, Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, United Kingdom – sequence: 6 givenname: Tom M. A. surname: Wilkinson fullname: Wilkinson, Tom M. A. organization: Clinical & Experimental Sciences and, Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, United Kingdom, Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, United Kingdom |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27115408$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UsuO0zAUjdAg5gE_wAJZYsMmxddxE2eDhDrAVCoUiUFiZznOzdQjxy62U6n8Fj-IS2cQzIKNbcnncR_nvDhx3mFRPAc6A6j566D1OGMUagolpZStF4-KM5hX85K3DT3Jb9pUJeftt9PiPMZbSoEJoE-KU9YAzDkVZ8XPLwmDN31pXD9p7MklDkYbdHpP_EA-TtpHZUsVo9dGpQxYup0KRrlErskCrY3EOJI2SBab4J3RZN3FFCadzA7J58mO3qmwJ5cmoopIVpO7mZHluLVGq2S8i2TwgXzyLu23qDqL5Erh6LcbY6eD9mAndD8UZuMB9YHxtHg8KBvx2d19UXx9_-56cVWu1h-Wi7erUvOKphLamgH0AufYcCF4BcgqEIqptoIOK971nNd1q7FT-WxrpZVqdA8MWsFqUV0Ub46626kbsdfoUlBWboMZc0fSKyP__XFmI2_8Ts4BOOcsC7y6Ewj--4QxydFEnWemHPopSsg2dUOFOHi9fAC99VNwub2M4lCLvN8qo178XdGfUu73mQHiCNDBxxhwkNqk32POBRorgcpDdOQhOvIYHXmMTqayB9R79f-QfgF5xMvY |
CitedBy_id | crossref_primary_10_1038_s41385_020_0331_5 crossref_primary_10_1038_s41385_021_00469_5 crossref_primary_10_4168_aair_2024_16_6_585 crossref_primary_10_3389_fimmu_2020_01014 crossref_primary_10_1016_j_ejphar_2022_174821 crossref_primary_10_3389_fimmu_2022_1107609 crossref_primary_10_1513_AnnalsATS_201807_441OC crossref_primary_10_1111_imm_12925 crossref_primary_10_1080_08820139_2023_2298398 crossref_primary_10_1186_s12931_021_01755_3 crossref_primary_10_4049_immunohorizons_2100003 crossref_primary_10_1016_j_molimm_2018_08_022 crossref_primary_10_3389_fimmu_2021_640455 crossref_primary_10_3389_fimmu_2022_819992 crossref_primary_10_1016_j_jaci_2021_07_037 crossref_primary_10_1183_13993003_00455_2022 crossref_primary_10_1111_imm_13653 crossref_primary_10_1016_j_jaci_2023_06_021 crossref_primary_10_1084_jem_20171739 crossref_primary_10_1183_13993003_01848_2017 crossref_primary_10_1007_s00281_019_00740_9 crossref_primary_10_1177_1753466621995050 crossref_primary_10_3390_life12030341 crossref_primary_10_1038_s41467_018_07207_9 crossref_primary_10_1007_s00011_019_01259_3 crossref_primary_10_1080_17476348_2022_2092099 crossref_primary_10_1016_j_cyto_2017_07_007 crossref_primary_10_1038_s41590_019_0444_8 crossref_primary_10_1164_rccm_201605_0942ED crossref_primary_10_1165_rcmb_2022_0131OC crossref_primary_10_3389_fimmu_2020_01845 crossref_primary_10_1002_JLB_4RI0118_023R crossref_primary_10_1016_j_vaccine_2021_10_044 crossref_primary_10_1183_13993003_00037_2017 crossref_primary_10_1016_j_jaci_2017_08_009 crossref_primary_10_1038_s41577_020_00477_9 crossref_primary_10_3389_fimmu_2019_01597 crossref_primary_10_1002_cpim_89 crossref_primary_10_1016_j_ekir_2024_11_007 crossref_primary_10_3390_v13020241 crossref_primary_10_3389_fimmu_2022_981740 crossref_primary_10_3389_fimmu_2020_01691 crossref_primary_10_3390_biom13020213 crossref_primary_10_1016_j_molimm_2018_09_026 crossref_primary_10_3389_fimmu_2021_748741 crossref_primary_10_1002_cpim_90 crossref_primary_10_1038_s41577_019_0191_y crossref_primary_10_1183_16000617_0008_2022 crossref_primary_10_3389_fimmu_2017_01837 crossref_primary_10_1016_j_imlet_2024_106910 crossref_primary_10_1111_cei_13377 crossref_primary_10_1016_j_chest_2018_01_020 crossref_primary_10_1038_s41572_021_00259_0 crossref_primary_10_1093_intimm_dxab109 crossref_primary_10_1183_16000617_0045_2017 crossref_primary_10_1016_j_alit_2023_07_006 crossref_primary_10_1186_s12931_017_0671_1 crossref_primary_10_3389_fimmu_2018_01602 crossref_primary_10_1128_microbiolspec_BAD_0005_2016 crossref_primary_10_1016_j_dci_2019_02_020 crossref_primary_10_3389_fimmu_2018_02530 crossref_primary_10_1016_j_celrep_2025_115275 crossref_primary_10_1016_j_intimp_2022_108606 crossref_primary_10_1186_s12950_024_00376_z crossref_primary_10_1080_08830185_2017_1365145 crossref_primary_10_3389_fimmu_2020_584521 crossref_primary_10_1002_cdt3_71 crossref_primary_10_1016_j_coi_2017_04_002 crossref_primary_10_1007_s10875_019_00640_5 crossref_primary_10_3389_fimmu_2023_1127588 crossref_primary_10_1038_s41467_018_05202_8 crossref_primary_10_1146_annurev_immunol_080719_015428 crossref_primary_10_4049_jimmunol_1900774 crossref_primary_10_4049_jimmunol_1701512 crossref_primary_10_1183_16000617_0041_2021 crossref_primary_10_1186_s12931_022_02045_2 crossref_primary_10_1038_s41423_020_00568_6 crossref_primary_10_1159_000487057 crossref_primary_10_1165_rcmb_2017_0162OC crossref_primary_10_3389_fimmu_2023_1264351 crossref_primary_10_1111_imr_13325 crossref_primary_10_1080_08830185_2017_1380199 crossref_primary_10_3389_falgy_2024_1439303 crossref_primary_10_1111_cei_13165 crossref_primary_10_1016_j_intimp_2021_107485 crossref_primary_10_1183_13993003_01582_2017 |
Cites_doi | 10.3389/fcimb.2011.00001 10.1002/eji.1830240508 10.1056/NEJMoa063070 10.1183/09031936.02.00000102 10.1164/rccm.201501-0044ST 10.1164/rccm.201302-0341OC 10.1016/j.rmed.2011.07.020 10.1056/NEJMoa064691 10.1164/rccm.201108-1553OC 10.1016/S1473-3099(14)70734-0 10.1080/15412550903140881 10.1182/blood-2011-05-353789 10.1111/j.1469-0691.2011.03700.x 10.1016/j.jaci.2012.07.023 10.1016/j.jaci.2015.01.014 10.1038/nature01433 10.1046/j.1365-3083.1996.d01-73.x 10.1016/j.rmed.2008.04.019 10.1182/blood-2005-05-2118 10.1371/journal.pbio.1000054 10.1056/NEJMoa012561 10.1016/B978-0-12-374279-7.06018-5 10.1016/S0140-6736(15)60357-9 10.1186/1465-9921-11-67 10.1164/rccm.200801-136OC 10.1164/ajrccm.164.11.2104093 10.1164/ajrccm.157.3.9707010 10.1136/bmj.320.7245.1297 10.1111/cei.12277 10.1038/ni.1890 10.1371/journal.pone.0121527 10.1111/j.1365-2710.2008.00970.x 10.1136/thorax.57.9.759 10.1002/eji.201343509 10.1378/chest.09-2992 10.1164/rccm.200708-1234OC 10.1016/S0140-6736(14)62447-8 10.1182/blood-2012-09-456095 10.1182/blood-2010-07-298372 10.1111/sji.12193 10.1164/rccm.201409-1654PP 10.1016/j.exger.2013.11.003 10.1097/MIB.0000000000000397 10.1093/nar/28.1.27 10.1186/1756-0500-6-522 10.1007/s00134-013-3163-x 10.1164/ajrccm/142.4.863 10.1164/rccm.201504-0782OC 10.1128/JVI.02789-13 10.1007/s00251-012-0666-5 10.1183/09031936.03.00031803 10.1111/imm.12582 10.5588/ijtld.15.0353 10.3109/15412555.2015.1069806 10.1038/ncomms3142 10.1016/S2213-2600(15)00242-8 10.1182/blood-2010-08-303339 10.1084/jem.189.12.1907 10.1038/nature11605 10.1073/pnas.1302799110 |
ContentType | Journal Article |
Copyright | Copyright American Thoracic Society Nov 15, 2016 Copyright © 2016 by the American Thoracic Society 2016 |
Copyright_xml | – notice: Copyright American Thoracic Society Nov 15, 2016 – notice: Copyright © 2016 by the American Thoracic Society 2016 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK ABUWG AFKRA AN0 BENPR CCPQU FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1164/rccm.201601-0002OC |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database (Proquest) ProQuest Central ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni) Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: Proquest Central Journals url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1535-4970 |
EndPage | 1218 |
ExternalDocumentID | PMC5114442 4255925271 27115408 10_1164_rccm_201601_0002OC |
Genre | Journal Article General Information |
GrantInformation_xml | – fundername: Wellcome Trust |
GroupedDBID | --- -~X .55 0R~ 23M 2WC 34G 39C 53G 5GY 5RE 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8FW 8R4 8R5 AAWTL AAYXX ABJNI ABOCM ABPMR ABUWG ACGFO ACGFS ADBBV AENEX AFCHL AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AN0 BAWUL BENPR BKEYQ BNQBC BPHCQ BVXVI C45 CCPQU CITATION CS3 DIK E3Z EBS EJD EMOBN EX3 F5P FRP FYUFA GX1 H13 HMCUK HZ~ IH2 J5H KQ8 L7B M1P M5~ NAPCQ O9- OBH OFXIZ OGEVE OK1 OVD OVIDX P2P PCD PHGZM PHGZT PQQKQ PROAC PSQYO Q2X RWL SJN TAE TEORI THO TR2 UKHRP W8F WH7 WOQ WOW X7M ~02 3V. CGR CUY CVF ECM EIF NPM RPM 7XB 8FK K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c430t-196211d8e5e7488431e2318a2a931be34bd44669ceba69c96acaa7cd121982683 |
IEDL.DBID | BENPR |
ISSN | 1073-449X 1535-4970 |
IngestDate | Thu Aug 21 13:35:37 EDT 2025 Thu Sep 04 18:24:35 EDT 2025 Fri Jul 25 04:30:35 EDT 2025 Wed Feb 19 02:43:35 EST 2025 Thu Apr 24 23:12:09 EDT 2025 Tue Jul 01 02:01:01 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | MAIT cell NTHi corticosteroids COPD |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c430t-196211d8e5e7488431e2318a2a931be34bd44669ceba69c96acaa7cd121982683 |
Notes | SourceType-Scholarly Journals-1 ObjectType-General Information-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this article. |
ORCID | 0000-0003-3844-6457 |
OpenAccessLink | http://doi.org/10.1164/rccm.201601-0002OC |
PMID | 27115408 |
PQID | 1841680023 |
PQPubID | 40575 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5114442 proquest_miscellaneous_1826670888 proquest_journals_1841680023 pubmed_primary_27115408 crossref_citationtrail_10_1164_rccm_201601_0002OC crossref_primary_10_1164_rccm_201601_0002OC |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-11-15 2016-Nov-15 20161115 |
PublicationDateYYYYMMDD | 2016-11-15 |
PublicationDate_xml | – month: 11 year: 2016 text: 2016-11-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: New York |
PublicationTitle | American journal of respiratory and critical care medicine |
PublicationTitleAlternate | Am J Respir Crit Care Med |
PublicationYear | 2016 |
Publisher | American Thoracic Society |
Publisher_xml | – name: American Thoracic Society |
References | bib36 bib37 bib34 bib35 bib32 bib33 bib30 bib31 bib29 bib27 bib28 bib40 bib47 bib48 bib45 bib46 bib43 bib44 bib41 bib42 bib7 bib8 bib5 bib3 bib38 bib4 bib39 bib1 bib2 bib50 bib51 bib14 bib58 bib15 bib59 bib12 bib56 bib13 bib57 bib10 bib54 bib11 bib55 bib52 bib53 bib49 bib61 bib62 bib60 bib25 bib26 bib23 bib24 bib21 bib22 bib20 Otczyk DC (bib9) 2011; 6 bib18 bib19 bib16 bib17 King PT (bib6) 2015; 2015 24322275 - Intensive Care Med. 2014 Feb;40(2):192-201 25946569 - Inflamm Bowel Dis. 2015 Jul;21(7):1529-40 23051753 - Nature. 2012 Nov 29;491(7426):717-23 26552490 - COPD. 2016;13(2):196-202 9517616 - Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):950-6 21760721 - Int J Chron Obstruct Pulmon Dis. 2011;6:345-51 8633212 - Scand J Immunol. 1996 May;43(5):537-44 12361359 - Eur Respir J Suppl. 2002 Sep;37:1s-2s 19278296 - PLoS Biol. 2009 Mar 10;7(3):e54 24269212 - Exp Gerontol. 2014 Jan;49:47-54 20576732 - Chest. 2011 Mar;139(3):505-12 12181400 - N Engl J Med. 2002 Aug 15;347(7):465-71 17314337 - N Engl J Med. 2007 Feb 22;356(8):775-89 10592173 - Nucleic Acids Res. 2000 Jan 1;28(1):27-30 24321049 - BMC Res Notes. 2013 Dec 09;6:522 22070637 - Clin Microbiol Infect. 2012 Sep;18(9):918-23 18079493 - Am J Respir Crit Care Med. 2008 Mar 1;177(5):491-7 22919570 - Front Cell Infect Microbiol. 2011 Nov 18;1:1 25409118 - Am J Respir Crit Care Med. 2015 Jan 15;191(2):141-8 26688539 - Int J Tuberc Lung Dis. 2016 Jan;20(1):129-35 23898209 - Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):E3119-28 24846411 - Scand J Immunol. 2014 Oct;80(4):271-5 26165134 - Lancet Respir Med. 2015 Sep;3(9):729-34 21084709 - Blood. 2011 Jan 27;117(4):1250-9 23229473 - Immunogenetics. 2013 Feb;65(2):115-24 23223428 - Blood. 2013 Jan 24;121(4):614-23 22447964 - Am J Respir Crit Care Med. 2012 Jul 1;186(1):48-55 23846752 - Nat Commun. 2013;4:2142 18614347 - Respir Med. 2008 Aug;102(8):1099-108 2221594 - Am Rev Respir Dis. 1990 Oct;142(4):863-71 16282346 - Blood. 2006 May 1;107(9):3575-83 19863361 - COPD. 2009 Oct;6(5):320-9 10377186 - J Exp Med. 1999 Jun 21;189(12):1907-21 26778581 - Immunology. 2016 May;148(1):1-12 10807619 - BMJ. 2000 May 13;320(7245):1297-303 22086415 - Blood. 2012 Jan 12;119(2):422-33 21119115 - Blood. 2011 Feb 3;117(5):1522-9 25012226 - Lancet Infect Dis. 2014 Dec;14(12):1281-92 26312864 - Lancet. 2015 Feb 26;385 Suppl 1:S42 19125898 - J Clin Pharm Ther. 2009 Feb;34(1):1-12 25775126 - PLoS One. 2015 Mar 16;10(3):e0121527 26114124 - J Immunol Res. 2015;2015:706376 26517304 - Am J Respir Crit Care Med. 2016 Mar 15;193(6):642-51 22033040 - Respir Med. 2012 Feb;106(2):257-68 8181517 - Eur J Immunol. 1994 May;24(5):1061-5 11739144 - Am J Respir Crit Care Med. 2001 Dec 1;164(11):2114-9 20513241 - Respir Res. 2010 May 31;11:67 25830527 - Am J Respir Crit Care Med. 2015 Apr 1;191(7):e4-e27 12762338 - Eur Respir J. 2003 Apr;21(4):574-81 22981793 - J Allergy Clin Immunol. 2012 Dec;130(6):1404-12.e7 27845580 - Am J Respir Crit Care Med. 2016 Nov 15;194(10 ):1177-1178 25746968 - J Allergy Clin Immunol. 2015 Aug;136(2):323-33 18787220 - Am J Respir Crit Care Med. 2008 Dec 15;178(12):1271-81 24352438 - J Virol. 2014 Mar;88(5):2366-73 24019201 - Eur J Immunol. 2014 Jan;44(1):195-203 12200518 - Thorax. 2002 Sep;57(9):759-64 20581831 - Nat Immunol. 2010 Aug;11(8):701-8 24450998 - Clin Exp Immunol. 2014 May;176(2):266-74 23992479 - Am J Respir Crit Care Med. 2013 Nov 15;188(10):1224-31 25608756 - Lancet. 2015 Apr 18;385(9977):1511-8 12634786 - Nature. 2003 Mar 13;422(6928):164-9 17409322 - N Engl J Med. 2007 Apr 5;356(14):1410-22 |
References_xml | – ident: bib7 doi: 10.3389/fcimb.2011.00001 – ident: bib56 doi: 10.1002/eji.1830240508 – ident: bib13 doi: 10.1056/NEJMoa063070 – ident: bib31 doi: 10.1183/09031936.02.00000102 – ident: bib3 doi: 10.1164/rccm.201501-0044ST – ident: bib54 doi: 10.1164/rccm.201302-0341OC – ident: bib14 doi: 10.1016/j.rmed.2011.07.020 – ident: bib33 doi: 10.1056/NEJMoa064691 – ident: bib60 doi: 10.1164/rccm.201108-1553OC – ident: bib5 doi: 10.1016/S1473-3099(14)70734-0 – volume: 2015 start-page: 706376 year: 2015 ident: bib6 publication-title: J Immunol Res – ident: bib17 doi: 10.1080/15412550903140881 – ident: bib35 doi: 10.1182/blood-2011-05-353789 – ident: bib10 doi: 10.1111/j.1469-0691.2011.03700.x – ident: bib37 doi: 10.1016/j.jaci.2012.07.023 – ident: bib20 doi: 10.1016/j.jaci.2015.01.014 – ident: bib28 doi: 10.1038/nature01433 – ident: bib59 doi: 10.1046/j.1365-3083.1996.d01-73.x – ident: bib16 doi: 10.1016/j.rmed.2008.04.019 – ident: bib57 doi: 10.1182/blood-2005-05-2118 – volume: 6 start-page: 345 year: 2011 ident: bib9 publication-title: Int J Chron Obstruct Pulmon Dis – ident: bib24 doi: 10.1371/journal.pbio.1000054 – ident: bib1 doi: 10.1056/NEJMoa012561 – ident: bib29 doi: 10.1016/B978-0-12-374279-7.06018-5 – ident: bib19 doi: 10.1016/S0140-6736(15)60357-9 – ident: bib50 doi: 10.1186/1465-9921-11-67 – ident: bib55 doi: 10.1164/rccm.200801-136OC – ident: bib8 doi: 10.1164/ajrccm.164.11.2104093 – ident: bib49 doi: 10.1164/ajrccm.157.3.9707010 – ident: bib12 doi: 10.1136/bmj.320.7245.1297 – ident: bib46 doi: 10.1111/cei.12277 – ident: bib34 doi: 10.1038/ni.1890 – ident: bib36 doi: 10.1371/journal.pone.0121527 – ident: bib44 doi: 10.1111/j.1365-2710.2008.00970.x – ident: bib51 doi: 10.1136/thorax.57.9.759 – ident: bib39 doi: 10.1002/eji.201343509 – ident: bib18 doi: 10.1378/chest.09-2992 – ident: bib2 doi: 10.1164/rccm.200708-1234OC – ident: bib40 doi: 10.1016/S0140-6736(14)62447-8 – ident: bib43 doi: 10.1182/blood-2012-09-456095 – ident: bib53 doi: 10.1182/blood-2010-07-298372 – ident: bib62 doi: 10.1111/sji.12193 – ident: bib15 doi: 10.1164/rccm.201409-1654PP – ident: bib61 doi: 10.1016/j.exger.2013.11.003 – ident: bib45 doi: 10.1097/MIB.0000000000000397 – ident: bib30 doi: 10.1093/nar/28.1.27 – ident: bib38 doi: 10.1186/1756-0500-6-522 – ident: bib47 doi: 10.1007/s00134-013-3163-x – ident: bib32 doi: 10.1164/ajrccm/142.4.863 – ident: bib52 doi: 10.1164/rccm.201504-0782OC – ident: bib48 doi: 10.1128/JVI.02789-13 – ident: bib25 doi: 10.1007/s00251-012-0666-5 – ident: bib58 doi: 10.1183/09031936.03.00031803 – ident: bib21 doi: 10.1111/imm.12582 – ident: bib11 doi: 10.5588/ijtld.15.0353 – ident: bib41 doi: 10.3109/15412555.2015.1069806 – ident: bib27 doi: 10.1038/ncomms3142 – ident: bib4 doi: 10.1016/S2213-2600(15)00242-8 – ident: bib23 doi: 10.1182/blood-2010-08-303339 – ident: bib22 doi: 10.1084/jem.189.12.1907 – ident: bib26 doi: 10.1038/nature11605 – ident: bib42 doi: 10.1073/pnas.1302799110 – reference: 24846411 - Scand J Immunol. 2014 Oct;80(4):271-5 – reference: 23898209 - Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):E3119-28 – reference: 12181400 - N Engl J Med. 2002 Aug 15;347(7):465-71 – reference: 16282346 - Blood. 2006 May 1;107(9):3575-83 – reference: 23229473 - Immunogenetics. 2013 Feb;65(2):115-24 – reference: 11739144 - Am J Respir Crit Care Med. 2001 Dec 1;164(11):2114-9 – reference: 19863361 - COPD. 2009 Oct;6(5):320-9 – reference: 22981793 - J Allergy Clin Immunol. 2012 Dec;130(6):1404-12.e7 – reference: 8181517 - Eur J Immunol. 1994 May;24(5):1061-5 – reference: 23051753 - Nature. 2012 Nov 29;491(7426):717-23 – reference: 2221594 - Am Rev Respir Dis. 1990 Oct;142(4):863-71 – reference: 10807619 - BMJ. 2000 May 13;320(7245):1297-303 – reference: 19278296 - PLoS Biol. 2009 Mar 10;7(3):e54 – reference: 23992479 - Am J Respir Crit Care Med. 2013 Nov 15;188(10):1224-31 – reference: 25608756 - Lancet. 2015 Apr 18;385(9977):1511-8 – reference: 24352438 - J Virol. 2014 Mar;88(5):2366-73 – reference: 25946569 - Inflamm Bowel Dis. 2015 Jul;21(7):1529-40 – reference: 20581831 - Nat Immunol. 2010 Aug;11(8):701-8 – reference: 22447964 - Am J Respir Crit Care Med. 2012 Jul 1;186(1):48-55 – reference: 26778581 - Immunology. 2016 May;148(1):1-12 – reference: 25746968 - J Allergy Clin Immunol. 2015 Aug;136(2):323-33 – reference: 22919570 - Front Cell Infect Microbiol. 2011 Nov 18;1:1 – reference: 23223428 - Blood. 2013 Jan 24;121(4):614-23 – reference: 18614347 - Respir Med. 2008 Aug;102(8):1099-108 – reference: 26688539 - Int J Tuberc Lung Dis. 2016 Jan;20(1):129-35 – reference: 26552490 - COPD. 2016;13(2):196-202 – reference: 18787220 - Am J Respir Crit Care Med. 2008 Dec 15;178(12):1271-81 – reference: 26312864 - Lancet. 2015 Feb 26;385 Suppl 1:S42 – reference: 25775126 - PLoS One. 2015 Mar 16;10(3):e0121527 – reference: 10377186 - J Exp Med. 1999 Jun 21;189(12):1907-21 – reference: 27845580 - Am J Respir Crit Care Med. 2016 Nov 15;194(10 ):1177-1178 – reference: 22086415 - Blood. 2012 Jan 12;119(2):422-33 – reference: 12762338 - Eur Respir J. 2003 Apr;21(4):574-81 – reference: 21084709 - Blood. 2011 Jan 27;117(4):1250-9 – reference: 25409118 - Am J Respir Crit Care Med. 2015 Jan 15;191(2):141-8 – reference: 23846752 - Nat Commun. 2013;4:2142 – reference: 26165134 - Lancet Respir Med. 2015 Sep;3(9):729-34 – reference: 8633212 - Scand J Immunol. 1996 May;43(5):537-44 – reference: 26114124 - J Immunol Res. 2015;2015:706376 – reference: 25012226 - Lancet Infect Dis. 2014 Dec;14(12):1281-92 – reference: 12361359 - Eur Respir J Suppl. 2002 Sep;37:1s-2s – reference: 21760721 - Int J Chron Obstruct Pulmon Dis. 2011;6:345-51 – reference: 17314337 - N Engl J Med. 2007 Feb 22;356(8):775-89 – reference: 24450998 - Clin Exp Immunol. 2014 May;176(2):266-74 – reference: 17409322 - N Engl J Med. 2007 Apr 5;356(14):1410-22 – reference: 24321049 - BMC Res Notes. 2013 Dec 09;6:522 – reference: 26517304 - Am J Respir Crit Care Med. 2016 Mar 15;193(6):642-51 – reference: 10592173 - Nucleic Acids Res. 2000 Jan 1;28(1):27-30 – reference: 24019201 - Eur J Immunol. 2014 Jan;44(1):195-203 – reference: 18079493 - Am J Respir Crit Care Med. 2008 Mar 1;177(5):491-7 – reference: 20576732 - Chest. 2011 Mar;139(3):505-12 – reference: 19125898 - J Clin Pharm Ther. 2009 Feb;34(1):1-12 – reference: 21119115 - Blood. 2011 Feb 3;117(5):1522-9 – reference: 22033040 - Respir Med. 2012 Feb;106(2):257-68 – reference: 12634786 - Nature. 2003 Mar 13;422(6928):164-9 – reference: 12200518 - Thorax. 2002 Sep;57(9):759-64 – reference: 20513241 - Respir Res. 2010 May 31;11:67 – reference: 25830527 - Am J Respir Crit Care Med. 2015 Apr 1;191(7):e4-e27 – reference: 24269212 - Exp Gerontol. 2014 Jan;49:47-54 – reference: 22070637 - Clin Microbiol Infect. 2012 Sep;18(9):918-23 – reference: 9517616 - Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):950-6 – reference: 24322275 - Intensive Care Med. 2014 Feb;40(2):192-201 |
SSID | ssj0012810 |
Score | 2.4957924 |
Snippet | Mucosal-associated invariant T (MAIT) cells are a recently described abundant, proinflammatory T-cell subset with unknown roles in pulmonary immunity.... Rationale: Mucosal-associated invariant T (MAIT) cells are a recently described abundant, proinflammatory T-cell subset with unknown roles in pulmonary... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1208 |
SubjectTerms | Adrenal Cortex Hormones - pharmacology Adult Aged Female Flow Cytometry Haemophilus Infections - complications Haemophilus Infections - immunology Haemophilus influenzae - immunology Humans Male Middle Aged Mucosal-Associated Invariant T Cells - drug effects Mucosal-Associated Invariant T Cells - immunology Original Pulmonary Disease, Chronic Obstructive - complications Pulmonary Disease, Chronic Obstructive - immunology Young Adult |
Title | Steroid-induced Deficiency of Mucosal-associated Invariant T Cells in the Chronic Obstructive Pulmonary Disease Lung. Implications for Nontypeable Haemophilus influenzae Infection |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27115408 https://www.proquest.com/docview/1841680023 https://www.proquest.com/docview/1826670888 https://pubmed.ncbi.nlm.nih.gov/PMC5114442 |
Volume | 194 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLZYJyFeEOO2wjYZiTcULRcnTnhB0G3qEO0m2KS-RY5zqlUKSVnXSfC3-IN8p3HDCtJe8uIT2_Gxj7-TcxPirQ9M78dTILfQjzzceIlnIIo9i7ux0D4ZozlQeDROhpfq8ySeuB9uC-dWuZaJK0FdNpb_kR8GbB9jdBN9mP_wuGoUW1ddCY0tsQ0RnMY9sf3peHz-tbMjhKnLR6AxEZVN1mEziTq8tpYj0YOE9Wn0ezbYvJr-w5v_uk3euYdOnojHDkDKjy3Hd8QDqp-KhyNnIn8mfn_DSjWz0oOyDbaV8og4SQRHWMpmKkfsoW4qzzi2gOC0voXCjBWWF3JAVbWQs1oCF0qXOFeeFS7L7C3J82WFlTDXP-VRa9qRXyAu3svTO57pEkBYjjnae04cmSWHhr4386tZteS-V1VRfhnCwK0jWP1cXJ4cXwyGnqvM4FkV-Tceji0UxzKlmDQkAEAIASemJjRZFBQUqaJkO3FmqTB4ZomxYLotA8hH6DNp9EL06qamXSFVotISZDosAhUDPoSUKVNk4dRkvqK0L4I1U3Lr0pZz9YwqX6kvicqZkXnLyLxlZF-8696Zt0k77qXeW_M6dwd4kf_dbn3xpmvG0WN7iqmpWTIN0I2GmMYkX7Zboxsu1JznyEeL3tg0HQGn9d5sqWdXq_TegMBKqfDV_dN6LR7xV3BYZBDviR72Ae0DH90UB2JLTzSe6SA4cAfiD2QdFFY |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtNAFB2VVgI2qLwDBQYJVsiqPR6_kKoKklYJTdIKUik7d2xP1EjGDk1TVD6KTX-Qc-OxaUDqrptsZmLP5L7OzX0x9s4Gpre9CZCbsF0LFs-3FFSxlcI2JoGtlQqoUHgw9LvH8svYG6-x33UtDKVV1jpxqaizMqX_yLcdio8RunF3Zz8smhpF0dV6hEbFFgf68idctvlOrwP6vhdif2_U7lpmqoCVStc-t8BycHqyUHs6APfCgGpgnFAJFblOol2ZZBTjjFKdKHxGvkpx4DRzINvA4qGL595hG4AZEaRo4_Pe8OhrE7cQoel_EODiMhrXZTq-3D5LU6p8d3zy33GPw_aqKfwP3_6bpnnN7u1vsgcGsPJPFYc9ZGu6eMTuDkxI_jG7-gbKlNPMgnMPNsl4R1NTCqro5OWEDygjXuWWMmyADb3iAg46KMpHvK3zfM6nBQcO5aZRLz9MTFfbC82PFjl-eXV2yTtVKIn3oZ4-8t61THgO4M2HVF0-01QJxrtKfy9np9N8Qc9eTmH5pTReXCWeFU_Y8a3Q7ClbL8pCP2dc-jLMsC0QiSM9wBWhI6mSSExUZEsdtphTEyVOTZt0mtaRx0t3yZcxETKuCBlXhGyxD813ZlWTkBt3b9W0jo3CmMd_2bvF3jbLEHWK36hClwvaAzQVwCzgkM8q1mheJwLqq2RjJVhhmmYDtRFfXSmmp8t24oDcUkrx4uZjvWH3uqNBP-73hgcv2X26EZVkOt4WWwdP6FfAZufJayMQnJ3ctgz-AcxATjs |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtNAFB2VVKrYIN4ECgwSrJAVezx-ISEESaOENmkErZSdO7YnaiRjh6YpKr_Fjq_j3HhsGpC66yabmdhj39e5vi_GXtvA9LY3A3ITtmvB4vmWgiq2UtjGJLC1UgEVCo_G_uBYfp560y32u66FobTKWieuFXVWpvSNvONQfIzQjduZmbSISa__YfHdoglSFGmtx2lULLKvL3_AfVu-H_ZA6zdC9PeOugPLTBiwUuna5xbYDw5QFmpPB-BkGFMNvBMqoSLXSbQrk4zinVGqE4XfyFcpDp9mDuQcuDx0cd1bbDuAVQxbbPvT3njypYlhiND0QgjwEmQ0rUt2fNk5S1Oqgnd88uXxTIfdTbP4H9b9N2Xzig3s32V3DHjlHytuu8e2dHGf7YxMeP4B-_UVVCrnmQVHHyyT8Z6mBhVU3cnLGR9RdrzKLWVYAhuGxQWcdVCXH_GuzvMlnxccmJSbpr38MDEdbi80n6xyvHl1dsl7VViJH0BVvePDK1nxHCCcj6nSfKGpKowPlP5WLk7n-YquvZ7I8lNp3LhKQisesuMbodkj1irKQj9hXPoyzLAtEIkjPUAXoSOpkkjMVGRLHbaZUxMlTk3LdJrckcdr18mXMREyrggZV4Rss7fNfxZVw5Brd-_WtI6N8ljGf1m9zV41yxB7iuWoQpcr2gNkFcBE4JCPK9ZobicC6rFkYyXYYJpmA7UU31wp5qfr1uKA31JK8fT6Y71kO5C9-GA43n_GbtMDUXWm4-2yFlhCPwdMO09eGHng7OSmRfAPGHVSZw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Steroid-induced+Deficiency+of+Mucosal-associated+Invariant+T+Cells+in+the+Chronic+Obstructive+Pulmonary+Disease+Lung.+Implications+for+Nontypeable+Haemophilus+influenzae+Infection&rft.jtitle=American+journal+of+respiratory+and+critical+care+medicine&rft.au=Hinks%2C+Timothy+S+C&rft.au=Wallington%2C+Joshua+C&rft.au=Williams%2C+Anthony+P&rft.au=Djukanovi%C4%87%2C+Ratko&rft.date=2016-11-15&rft.eissn=1535-4970&rft.volume=194&rft.issue=10&rft.spage=1208&rft_id=info:doi/10.1164%2Frccm.201601-0002OC&rft_id=info%3Apmid%2F27115408&rft.externalDocID=27115408 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1073-449X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1073-449X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1073-449X&client=summon |